DarioHealth (NASDAQ:DRIO) Shares Pass Below Two Hundred Day Moving Average – Time to Sell?

Shares of DarioHealth Corp. (NASDAQ:DRIO) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.81 and traded as low as $0.64. DarioHealth shares last traded at $0.68, with a volume of 100,221 shares traded.

Analyst Upgrades and Downgrades

Several research firms have issued reports on DRIO. TD Cowen downgraded DarioHealth from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $2.00 to $1.00 in a report on Wednesday, January 29th. Stifel Nicolaus cut their price target on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th.

DarioHealth Stock Performance

The stock’s 50 day moving average is $0.69 and its two-hundred day moving average is $0.81. The firm has a market capitalization of $29.32 million, a P/E ratio of -0.75 and a beta of 1.42. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in DRIO. XTX Topco Ltd increased its holdings in DarioHealth by 81.4% in the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock valued at $33,000 after purchasing an additional 13,219 shares during the last quarter. DLK Investment Management LLC grew its position in shares of DarioHealth by 40.9% during the 4th quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock worth $111,000 after buying an additional 41,107 shares during the period. Finally, Appian Way Asset Management LP increased its stake in shares of DarioHealth by 2.5% in the 3rd quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock valued at $1,580,000 after acquiring an additional 34,990 shares during the last quarter. Institutional investors and hedge funds own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.